HanchorBio Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-1,069	-1,354	-591.36	-446.32
Depreciation & Amortization	36.49	36.28	33.04	26.12
Other Amortization	1.14	1.12	0.84	0.75
Loss (Gain) From Sale of Investments	-0.46	-1.12	-0.94	-1.13
Stock-Based Compensation	287.23	311.96	47.9	37.33
Other Operating Activities	205.91	399.21	62.51	-81.63
Change in Accounts Receivable	-16.89	-1.31	0.05	2.29
Change in Accounts Payable	21.96	1.72	14.52	124.77
Change in Other Net Operating Assets	0.49	-0.56	-6.15	0.22
Operating Cash Flow	-532.97	-606.79	-439.59	-337.62
Capital Expenditures	-16.36	-18.78	-22.04	-70.78
Sale (Purchase) of Intangibles	-0.19	-0.19	-1.14	-
Investment in Securities	50.9	76.36	-87.71	1.13
Investing Cash Flow	34.35	57.39	-110.9	-69.65
Short-Term Debt Issued	-	26.24	29.69	-
Long-Term Debt Issued	-	-	-	20
Total Debt Issued	116.4	26.24	29.69	20
Short-Term Debt Repaid	-	-30.47	-	-
Long-Term Debt Repaid	-	-20.1	-20.07	-11.39
Total Debt Repaid	-58.54	-50.57	-20.07	-11.39
Net Debt Issued (Repaid)	57.86	-24.33	9.62	8.61
Issuance of Common Stock	120.53	120.08	-	-
Other Financing Activities	535.69	509.22	635.6	491.09
Financing Cash Flow	714.01	604.98	645.22	499.7
Foreign Exchange Rate Adjustments	-12.57	8.05	1.05	12.53
Net Cash Flow	202.83	63.63	95.78	104.97
Free Cash Flow	-549.32	-625.57	-461.63	-408.39
Free Cash Flow Margin	-	-	-	-12143.74%
Free Cash Flow Per Share	-5.64	-9.41	-8.87	-9.23
Cash Interest Paid	4.26	4.9	2.74	2.5
Levered Free Cash Flow	-	-179.45	-296.65	-
Unlevered Free Cash Flow	-	-176.39	-294.92	-
Change in Working Capital	5.56	-0.15	8.42	127.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.